These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30543888)

  • 1. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data.
    Mittapalli RK; Marroum P; Qiu Y; Apfelbaum K; Xiong H
    Pharm Res; 2017 Jul; 34(7):1527-1533. PubMed ID: 28512718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
    Kesisoglou F; Rossenu S; Farrell C; Van Den Heuvel M; Prohn M; Fitzpatrick S; De Kam PJ; Vargo R
    J Pharm Sci; 2014 Nov; 103(11):3713-3723. PubMed ID: 25256703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
    Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
    Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of a minipig model in assessing clinical bioperformance of matrix and multiparticulate extended-release formulations for a BCS class III Drug development candidate.
    Kesisoglou F; Xie IH; Manser K; Wu Y; Hardy I; Fitzpatrick S
    J Pharm Sci; 2014 Feb; 103(2):636-42. PubMed ID: 24382706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.
    Klančar U; Baumgartner S; Legen I; Smrdel P; Kampuš NJ; Krajcar D; Markun B; Kočevar K
    AAPS PharmSciTech; 2015 Apr; 16(2):398-406. PubMed ID: 25331194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study.
    Lee DY; Shin S; Kim TH; Shin BS
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Sustained Release System Based on High Water-Absorbable Gel Formation Using Croscarmellose Sodium, Alkaline Excipients and HPMC (ACSH SR System); Novel Application of Croscarmellose Sodium as a Gel Former.
    Gomi M; Mizutani N; Senoo R; Matsubara N; Watanabe A; Maruyama M; Kimura G; Higaki K
    Pharm Res; 2023 Dec; 40(12):3073-3086. PubMed ID: 37964084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of oseltamivir phosphate dual-phase extended-release tablets for the treatment of influenza.
    Yu L; Huang X; Jiang M; Guo W; Li X; Huang F; You J
    Int J Pharm; 2024 Aug; 661():124364. PubMed ID: 38914352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
    Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
    Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannitol-coated hydroxypropyl methylcellulose as an alternative directly compressible controlled release excipient.
    Kang CYX; Foo WC; Lam KH; Chow KT; Lui YS; Goh HP; Salome A; Boit B; Lefevre P; Hiew TN; Gokhale R; Heng PWS
    Int J Pharm; 2024 Jul; 660():124298. PubMed ID: 38825172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl Methylcellulose (Cellulose Ethers) Tablets Based on Its Degree of Polymerization.
    Kasabe AJ; Kulkarni AS; Gaikwad VL
    AAPS PharmSciTech; 2019 Sep; 20(8):308. PubMed ID: 31520165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
    Vemula SK
    AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.